Discovery of the molecular code for redox-related signaling

Initiation of molecular modeling

against BRD4 target molecule

•MSA with Wuxi Apptec Contract

•Patent Filing

•Established Epigenetics Research Institute

  (R&D Center)

•KWB-BR01, -02, -03, -04 P.O.C. Studies

•Preclinical Test

Identification of redox model including

Identification of anti-cancer & anti-inflammatory mechanism

•Completed four BRD4 target molecular 

  modeling

•BenoBio Co., Ltd. established

•Collaboration with the Catholic University

  of Korea Hospital

•Drug Delivery System

  technology  Contract with Germany

•Contract with the Catholic University of

  Korea